Sana Biotechnology, Inc. SANA
$2.83
▼ -3.25% 24H
About
Sana Biotechnology, Inc. is a clinical-stage biotechnology company developing engineered cell therapies to repair and control genes in cells or replace missing or damaged cells, addressing the underlying causes of diseases. The company focuses on two primary platforms: hypoimmune technology, which modifies cells to eva…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees142
TickerSANA
Statistics
Market Cap$762.2M
Revenue (TTM)$0
Net Income-$244.2M
Net Margin—
EPS$-0.96
P/E-2.89
P/S—
P/B4.59
EV/EBITDA-4.46
ROE-147.4%
Dividend Yield—
Price$2.83
Data: Twelve Data · Revenue = mcap / P/S